Polymorphism of platelet membrane glycoprotein IIIa:: Human platelet antigen 1b (HPA-1b/PIA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease

被引:77
作者
Zotz, RB
Winkelmann, BR
Nauck, M
Giers, G
Maruhn-Debowski, B
März, W
Scharf, RE [1 ]
机构
[1] Heinrich Heine Univ, Ctr Med, Dept Haemostasis & Transfus Med, D-40225 Dusseldorf, Germany
[2] Goethe Univ Frankfurt, Ctr Med, Dept Cardiol, Frankfurt, Germany
[3] Albert Ludwigs Univ, Div Clin Chem, Freiberg, Germany
关键词
D O I
10.1055/s-0037-1615054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Conflicting results of an association between the human platelet antigen 1b (HPA-1b or P1(A2)) allele and the risk of myocardial infarction and coronary artery disease have been reported. To assess the reason for this discrepancy, we determined the HPA-1 genotype in 298 men who had undergone coronary angiography, including 124 individuals with myocardial infarction, 83 individuals with coronary artery disease but no history of myocardial infarction, and 91 control patients. Among patients with acute or recent onset myocardial infarction (<1 year), the prevalence of HPA-1b was higher than among patients with coronary artery disease but without myocardial infarction (33 percent vs. 14 percent, p = 0.016). In patients under 60 years of age this difference was even more pronounced (45 percent vs. 15 percent, p = 0.003). Unlike conventional risk factors HPA-1b does not represent a risk factor for coronary artery disease itself but appears to be associated with increased platelet thrombogenicity.
引用
收藏
页码:731 / 735
页数:5
相关论文
共 34 条
[1]  
[Anonymous], 1988, LANCET, V2, P349
[2]  
Austen W G, 1975, Circulation, V51, P5
[3]   USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].
CALIFF, RM ;
SHADOFF, N ;
VALETT, N ;
BATES, E ;
GALEANA, A ;
KNOPF, W ;
SHAFTEL, J ;
BENDER, MJ ;
AVERSANO, T ;
RAQUENO, J ;
GURBEL, P ;
COWFER, J ;
COHEN, M ;
CROSS, P ;
BITTL, J ;
EDDINGS, K ;
TAYLOR, M ;
DEROSA, K ;
HATTEL, L ;
COOPER, L ;
ESHELMAN, B ;
FINTEL, D ;
NIEMYSKI, P ;
KLEIN, L ;
KENNEDY, H ;
THORNTON, T ;
KEREIAKES, D ;
MARTIN, L ;
ANDERSON, L ;
HIGBY, N ;
ELLIS, S ;
BREZINA, K ;
GEORGE, B ;
CHAPEKIS, A ;
SMITH, D ;
ANWAR, A ;
GERBER, TL ;
PRITCHARD, GL ;
MYLER, R ;
SHAW, R ;
MURPHY, M ;
WARD, K ;
MADIGAN, NP ;
BLANKENSHIP, J ;
HALBERT, M ;
FLANAGAN, C ;
TANNENBAUM, M ;
POLICH, M ;
STEVENSON, C ;
TCHENG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961
[4]  
Carter AM, 1996, NEW ENGL J MED, V335, P1072
[5]   BLOCKADE OF PLATELET GPIIB/IIIA RECEPTORS AS AN ANTITHROMBOTIC STRATEGY [J].
COLLER, BS .
CIRCULATION, 1995, 92 (09) :2373-2380
[6]   CORONARY ARTERIOGRAPHIC FINDINGS SOON AFTER NON-Q-WAVE MYOCARDIAL-INFARCTION [J].
DEWOOD, MA ;
STIFTER, WF ;
SIMPSON, CS ;
SPORES, J ;
EUGSTER, GS ;
JUDGE, TP ;
HINNEN, ML .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (07) :417-423
[7]   PLATELET ACTIVATION IN UNSTABLE CORONARY-DISEASE [J].
FITZGERALD, DJ ;
ROY, L ;
CATELLA, F ;
FITZGERALD, GA .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (16) :983-989
[8]   MECHANISMS OF DISEASE - THE PATHOGENESIS OF CORONARY-ARTERY DISEASE AND THE ACUTE CORONARY SYNDROMES .1. [J].
FUSTER, V ;
BADIMON, L ;
BADIMON, JJ ;
CHESEBRO, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (04) :242-250
[9]   PHARMACODYNAMIC STUDY OF F(AB')2 FRAGMENTS OF MURINE MONOCLONAL ANTIBODY-7E3 DIRECTED AGAINST HUMAN PLATELET GLYCOPROTEIN-IIB/IIIA IN PATIENTS WITH UNSTABLE ANGINA-PECTORIS [J].
GOLD, HK ;
GIMPLE, LW ;
YASUDA, T ;
LEINBACH, RC ;
WERNER, W ;
HOLT, R ;
JORDAN, R ;
BERGER, H ;
COLLEN, D ;
COLLER, BS .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (02) :651-659
[10]  
Herrmann SM, 1997, THROMB HAEMOSTASIS, V77, P1179